Justice ministry confirms legal aid requests in Greece-Novartis scandal
Switzerland’s Federal Office of Justice has confirmed it has received two requests for legal assistance from Greece and the United States linked to probes into Novartis and alleged bribes involving the Swiss drugmaker and Greek doctors and public officials.
This content was published on
2 minutes
SDA-ATS/RTS/sb
The two requests for legal assistance linked to the Novartis-Greek scandal were received at the end of last year and in January 2018 and are being studied, a justice ministry official confirmed to Swiss public television, RTS, and the Swiss News Agency on Saturday.
The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based NovartisExternal link over nearly a decade to boost subscriptions of their products at public hospitals. The ten prominent politicians linked to the bribery scandal include two former Greek prime ministers and eight former ministers. They are alleged to have been involved in approving Novartis contracts and overcharging in return for kickbacks. All deny the allegations.
Greece’s Justice Minister Stavros Kontonis last year said Novartis had likely bribed “thousands” of doctors and civil servants to promote its products. He also accused Novartis of continuing to sell “overpriced” drugs even after the country was plunged into economic crisis in 2010 and huge cuts were imposed on state budgets, leaving many Greeks without access to affordable medicine.
Novartis overcharges alone are estimated to have cost the Greek state some €3 billion euros ($3.7 billion). Overall, similar practises across the health sector cost Greece some €23 billion between 2000 and 2015, investigators have said.
The Greek branch of Novartis has issued a statement saying it was “aware of the media reports about our business practices” in Greece and that it was cooperating with the authorities, the Swiss News Agency said.
More
More
Greece investigates Novartis for alleged bribery
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
Federal offices and Xplain adopt data protection recommendations
This content was published on
Swiss authorities and its private contract processors are required to review their cooperation after an investigation into leaked data.
This content was published on
Heavy rainfall has caused severe flooding in northern Armenia and cost lives. Switzerland dispatched a team of seven engineers to the region.
Swiss House of Representatives does not want to recognise Palestine as a state
This content was published on
By 131 votes to 61 with 2 abstentions, the House of Representatives said 'no' to the postulate put forth by the Social Democratic Party.
This content was published on
The peak of the snow accumulation was most likely reached on Monday, wrote glaciologist Matthias Huss on the social media platform X on Tuesday.
US Vice President Harris to attend Ukraine peace conference
This content was published on
US Vice President Kamala Harris and US President Joe Biden's security advisor, Jake Sullivan, will take part in the Ukraine peace conference.
FINMA director expects cooperation and transparency from banks
This content was published on
"I demand complete and unfiltered access to all information", said the director of the Swiss Financial Market Supervisory Authority said in an interview.
Swiss Senate wants additional billions for the army
This content was published on
The increase in the payment framework is intended to ensure that the army budget reaches the target value of 1% of gross domestic product by 2030.
Swiss Senate rejects special fund for army and Ukraine
This content was published on
There will be no CHF15 billion ($17 billion) special fund for the army and reconstruction in Ukraine. The Senate has clearly rejected a motion by its security policy committee.
Earthquake service reports 4.4 magnitude quake in central Switzerland
This content was published on
The earthquake was probably felt throughout Switzerland, according to the Swiss Seismological Service of federal technology institute ETH Zurich.
This content was published on
Investigations into allegations of corruption against the pharma giant were announced following the attempted suicide of a Greek Novartis official.
This content was published on
Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
This content was published on
The employees are believed to have offered illegal rebates and kickbacks to doctors amounting to 2.6 billion won (CHF 2.3 million) between 2011 and 2016. Altogether, 34 people – including 15 doctors and five heads of medical journals – have been included in the investigation, which began in February when authorities raided the Novartis Korea…
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
This content was published on
Swiss pharmaceutical giant Novartis has dismissed claims from an internal whistleblower that it bribed Turkish officials.
Pharma turns to big data to gauge care and pricing
This content was published on
Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.